IBCL-1346: Comparative Effectiveness of Epcoritamab, Lenalidomide, and Rituximab in EPCORE FL-1 vs Real-World Chemoimmunotherapy in Relapsed/Refractory Follicular Lymphoma
Year: 2026
Type: article
Authors: Habte Yimer, Lorenzo Falchi, Rong Tao, Loic Ysebaert, Michal Kwiatek, Abel Costa, Theodoros P Vassilakopoulos, Marcel Nijland, Shane Gangatharan, Dai Maruyama, Abualbishr Alshreef, Anthony Wang, Junhua Yu, David Tybor, Yves Mbous, Kavita Sail, Zhijie Ding, Gauri Sunkersett, JP Mei, Kim Linton
Institutions: Texas Oncology, Memorial Sloan Kettering Cancer Center, Fudan University, Fudan University Shanghai Cancer Center, Institut universitaire du cancer de Toulouse Oncopole, Université de Toulouse, D’Or Institute for Research and Education, National and Kapodistrian University of Athens, Laiko General Hospital of Athens, University Medical Center Groningen, University of Groningen, Fiona Stanley Hospital, The Cancer Institute Hospital, Japanese Foundation For Cancer Research, AbbVie (United States), Genmab (United States), University of Manchester, The Christie NHS Foundation Trust, Cancer Research UK Manchester Centre
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7204708111
FWCI:
Cites:
Cited by:
Related to: